Article Listing - Elan 1st-qtr net loss widens 20% to $102.6M

SANDOZ LAUNCHES ICAZ LP IN FRANCE

9 March 1992

Sandoz has launched a sustained-release formulation of the calcium channel blocker isradipine onto the French market. The product is now...

CHOLINE KEY TO ALZHEIMER'S?

9 March 1992

New research has indicated that a deficiency of the acetylcholine precursor choline may be a prime factor in the etiology...

RETROVIR AND AIDS PATIENT SURVIVAL

9 March 1992

Backing that Wellcome's antiretroviral product Retrovir (zidovudine) improves the survival of patients with AIDS has come from a study by...

FDA PLANS MOVES ON DRUG ADS

9 March 1992

The US Food and Drug Administra-tion has recently issued 10-15 letters on violative reminder ads for prescription drugs and is...

UK NURSE PRESCRIBING MOVES

9 March 1992

Despite the speedy passage through Parliament of UK legislation to permit nurse prescribing, the enabling regulations are unlikely to be...

FDA FRAUD POLICY EXPLAINED

9 March 1992

Application by the US Food and Drug Administration of its fraud policy against companies suspected of wrongdoing would not slow...

INTERPHARM AND rIL-6

9 March 1992

InterPharm Labs has receiv-ed conditional approval from Israel's Ministry of Industry and Trade to license Ares-Serono Group's worldwide rights to...

LITHIUM AND PREGNANCY

9 March 1992

Results of a prospective multicenter study of pregnancy outcome after lithium exposure during the first trimester suggest that it is...

NEW CEO AT BOEH MANNHEIM CORP, USA

9 March 1992

Andre de Bruin is named president and chief executive officer of Boehringer Mannheim Corp, USA. He succeeds Robert Schwindt, who...

BAYER AG'S JONATHAN TALBUTT

9 March 1992

Jonathan Talbutt is appointed international product manager, diabetes, at Bayer AG, based in Leverkusen, Germany.

Showing 94711-94720 of 95329 articles

Go to beginningPreviousNextGo to end